USE OF HIGH POTENCY STATINS FOR PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: PRACTICE IMPACT OF THE NEW CHOLESTEROL GUIDELINES

被引：0
|
作者：
Rodriguez, Fatima [1 ]
Heidenreich, Paul [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61436-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-104
引用
收藏
页码：A1436 / A1436
页数：1
相关论文
共 50 条
  • [31] Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease
    Huang, Bao-tao
    Peng, Yong
    Huang, Fang-yang
    Xia, Tian-li
    Gui, Yi-yue
    Liao, Yan-biao
    Pu, Xiao-bo
    Chen, Shi-jian
    Yang, Yong
    Chen, Mao
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (08) : 1121 - 1129
  • [32] Patient-Centered and Practical Application of New High Cholesterol Guidelines to Prevent Cardiovascular Disease
    Montori, Victor M.
    Brito, Juan P.
    Ting, Henry H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (05): : 465 - 466
  • [33] Lipid-lowering therapy for the prevention of atherosclerotic cardiovascular disease: guidelines and clinical practice
    Lucchi, Tiziano
    Cesari, Matteo
    Vergani, Carlo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (04) : 256 - 263
  • [34] Choice of initial treatment with cholesterol lowering drugs in patients with familial hypercholesterolemia, atherosclerotic cardiovascular disease, or increased risk of atherosclerotic cardiovascular disease
    Hoe, Jakob Kronkvist
    Jensen, Camilla B.
    Hansen, Susanne
    Olsen, Rasmus Huan
    Johansen, Tina
    Jimenez-Solem, Espen
    Petersen, Janne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 178 - 179
  • [35] Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease
    Stern, MP
    Williams, K
    Hunt, KJ
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (02) : 3 - 6
  • [36] Impact of new Joint British Societies' Guidelines on Prevention of Cardiovascular Disease: evaluation of serum total cholesterol goal achievement in UK clinical practice
    Rajagopalan, S.
    Alemao, E.
    Yin, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 391 - 391
  • [37] Atherosclerotic Cardiovascular Disease Prevention A Comparison Between the Third Adult Treatment Panel and the New 2013 Treatment of Blood Cholesterol Guidelines
    Paixao, Andre R. M.
    Ayers, Colby R.
    Berry, Jarett D.
    de Lemos, James A.
    Khera, Amit
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (05): : 778 - U204
  • [38] Impact of New Clinical Practice Guidelines on Cardiovascular Disease Risk Assessment in an Obese Pediatric Population
    Binka, Edem
    Spevak, Philip
    Dibert, Lauren
    Brady, McLoughlin Tammy
    HYPERTENSION, 2018, 72
  • [39] Statins for high-risk patients without heart disease or high cholesterol
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1225): : 1 - 3
  • [40] Application of New Guidelines for the Primary Prevention of Atherosclerotic Cardiovascular Disease in a Korean Population
    Kim, Nan Hee
    So, Min-Suk
    Kang, Jeong-Gyu
    Cho, Dong-Sik
    Byrne, Christopher D.
    Lee, Sang Jong
    Sung, Ki-Chul
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (03) : 293 - 303
12345